by | Sep 4, 2023 | Publications
Biol Pharm Bull. 2023;46(9):1269-1276. doi: 10.1248/bpb.b23-00228. ABSTRACT Adult T-cell leukemia/lymphoma (ATL) is a hematopoietic malignancy with a poor prognosis that develops in approximately 5% of human T-cell leukemia virus type 1 (HTLV-1) carriers....
by | Sep 4, 2023 | Publications
Intern Med. 2023 Sep 1. doi: 10.2169/internalmedicine.2201-23. Online ahead of print. ABSTRACT Human T-cell lymphotropic virus type-1 (HTLV-1)-associated bronchioloalveolar disorder (HABA) is a pulmonary disorder characterized by lymphocytic infiltration of the...
by | Sep 4, 2023 | Publications
J Med Virol. 2023 Sep;95(9):e29065. doi: 10.1002/jmv.29065. ABSTRACT Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retrovirus that causes adult T-cell leukemia/lymphoma (ATL). HTLV-1 encodes Tax protein that activates transcription from viral long...
by | Sep 4, 2023 | Publications
J Clin Virol. 2023 Aug 28;167:105578. doi: 10.1016/j.jcv.2023.105578. Online ahead of print. ABSTRACT BACKGROUND: HTLV-1 infection is a neglected disease, despite producing neurological and lymphoproliferative severe illnesses and affect over 10 million people...
by | Sep 2, 2023 | Publications
Immunobiology. 2023 Aug 25;228(6):152740. doi: 10.1016/j.imbio.2023.152740. Online ahead of print. ABSTRACT Human T-lymphotropic virus 1 (HTLV-1) affects 5-10 million individuals worldwide. Most of those infected with this virus remain asymptomatic; however, 0.25%-4%...
by | Aug 30, 2023 | Publications
AIDS Res Hum Retroviruses. 2023 Aug 30. doi: 10.1089/AID.2022.0174. Online ahead of print. ABSTRACT BACKGROUND: Despite the accuracy of confirmatory tests for the diagnosis of HTLV, inconclusive or false-negative results still occur when diagnosing HTLV-2 positive...
